Squarepoint
DGX icon

Squarepoint’s Quest Diagnostics DGX Stock Holding History

Squarepoint’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,200
Closed -$229K – 4389
2025
Q3 		$229K Buy
+1,200
New +$213K ﹤0.01% 3858
2025
Q2 		– Sell
-10,200
Closed -$1.73M – 4602
2025
Q1 		$1.73M Buy
10,200
+8,100
+386% +$1.33M ﹤0.01% 2210
2024
Q4 		$317K Sell
2,100
-10,200
-83% -$1.59M ﹤0.01% 4105
2024
Q3 		$1.91M Sell
12,300
-3,600
-23% -$538K ﹤0.01% 2109
2024
Q2 		$2.18M Buy
+15,900
New +$2.18M ﹤0.01% 1993
2023
Q4 		– Sell
-1,700
Closed -$207K – 4089
2023
Q3 		$207K Buy
+1,700
New +$227K ﹤0.01% 3389

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Squarepoint's DGX Position: Q2 2026 in Review

Squarepoint reduced its Quest Diagnostics (DGX) stake by 66% in Q2 2026, selling an estimated $44.7M and leaving 117,831 shares worth $25M. The position accounts for 0.03% of the portfolio, ranked #596.

Squarepoint first reported a position in DGX in Q2 2015 and has held it in 38 quarters since. The position peaked at $151M in Q2 2025. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Squarepoint held 117,831 shares of Quest Diagnostics worth $25M as of Q2 2026.
  • Squarepoint sold 227,957 Quest Diagnostics shares in Q2 2026, an estimated $44.7M.
  • Quest Diagnostics made up 0.03% of Squarepoint's portfolio in Q2 2026, its #596 holding.
  • Squarepoint first reported a position in Quest Diagnostics in Q2 2015 and has held it in 38 quarters since.
  • Squarepoint's Quest Diagnostics position peaked at $151M in Q2 2025.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.